Literature DB >> 1493846

Failure of N-acetylcysteine to reduce low-density lipoprotein oxidizability in healthy subjects.

H A Kleinveld1, P N Demacker, A F Stalenhoef.   

Abstract

We have studied the effects of N-acetylcysteine, which is thought to have antioxidant properties, on the susceptibility of low-density lipoprotein to oxidation and on whole-blood glutathione concentrations in six healthy volunteers. N-acetylcysteine was given orally in a dosage of at 1.2 g per day for 4 weeks, followed by 2.4 g per day for a further two weeks. The susceptibility of low-density lipoprotein to in vitro Cu(2+)-oxidation was determined by continuously measuring the formation of conjugated dienes. Whole-blood concentrations of reduced and oxidized glutathione were also determined. N-acetylcysteine had no effect on the susceptibility of LDL to oxidation. Concentrations of vitamin E in the serum and in low-density lipoprotein were not changed. Compared with controls the concentration of glutathione in N-acetylcysteine treated subjects was reduced (-48%) and the concentration of oxidized glutathione was higher (+80%). The GSH/GSSG-ratio, a marker of oxidative stress was 83% lower. The results do not support the supposed antioxidative action of N-acetylcysteine. It seems more likely that N-acetylcysteine acts as a pro-oxidant in the dosage used.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1493846     DOI: 10.1007/bf02284964

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  28 in total

Review 1.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

2.  N-acetylcysteine and lipoprotein.

Authors:  A F Stalenhoef; A A Kroon; P N Demacker
Journal:  Lancet       Date:  1991-02-23       Impact factor: 79.321

3.  Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects.

Authors:  J de Graaf; H L Hak-Lemmers; M P Hectors; P N Demacker; J C Hendriks; A F Stalenhoef
Journal:  Arterioscler Thromb       Date:  1991 Mar-Apr

4.  Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins.

Authors:  T Henriksen; E M Mahoney; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

5.  The effect of cysteine oxidation on isolated hepatocytes.

Authors:  J Viña; G T Saez; D Wiggins; A F Roberts; R Hems; H A Krebs
Journal:  Biochem J       Date:  1983-04-15       Impact factor: 3.857

6.  Improved procedure for determining glutathione in plasma as an index of myocardial oxidative stress.

Authors:  S Curello; C Ceconi; A Cargnoni; A Cornacchiari; R Ferrari; A Albertini
Journal:  Clin Chem       Date:  1987-08       Impact factor: 8.327

7.  The production of free radicals during the autoxidation of cysteine and their effect on isolated rat hepatocytes.

Authors:  G Saez; P J Thornalley; H A Hill; R Hems; J V Bannister
Journal:  Biochim Biophys Acta       Date:  1982-10-28

8.  Oxidation of low-density lipoprotein by thiol compounds leads to its recognition by the acetyl LDL receptor.

Authors:  S Parthasarathy
Journal:  Biochim Biophys Acta       Date:  1987-02-14

9.  Mechanism of action of N-acetylcysteine in the protection against the hepatotoxicity of acetaminophen in rats in vivo.

Authors:  B H Lauterburg; G B Corcoran; J R Mitchell
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

10.  Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases.

Authors:  G Boman; U Bäcker; S Larsson; B Melander; L Wåhlander
Journal:  Eur J Respir Dis       Date:  1983-08
View more
  9 in total

1.  Modulatory effect of N-acetylcysteine on pro-antioxidant status and haematological response in healthy men.

Authors:  A Zembron-Lacny; M Slowinska-Lisowska; Z Szygula; Z Witkowski; K Szyszka
Journal:  J Physiol Biochem       Date:  2010-03-31       Impact factor: 4.158

2.  Improved oxidative status in major abdominal surgery patients after N-acetyl cystein supplementation.

Authors:  Aygun Kuyumcu; Asli Akyol; Zehra Buyuktuncer; M Mahir Ozmen; Halit Tanju Besler
Journal:  Nutr J       Date:  2015-01-06       Impact factor: 3.271

3.  Antioxidant Treatment in Male Mice Prevents Mitochondrial and Synaptic Changes in an NMDA Receptor Dysfunction Model of Schizophrenia.

Authors:  Aarron Phensy; Christopher Driskill; Karen Lindquist; Lan Guo; Vivek Jeevakumar; Bryan Fowler; Heng Du; Sven Kroener
Journal:  eNeuro       Date:  2017-08-17

Review 4.  Dietary thiols in exercise: oxidative stress defence, exercise performance, and adaptation.

Authors:  Yanita McLeay; Stephen Stannard; Stuart Houltham; Carlene Starck
Journal:  J Int Soc Sports Nutr       Date:  2017-04-27       Impact factor: 5.150

Review 5.  Nutrition and Altitude: Strategies to Enhance Adaptation, Improve Performance and Maintain Health: A Narrative Review.

Authors:  Trent Stellingwerff; Peter Peeling; Laura A Garvican-Lewis; Rebecca Hall; Anu E Koivisto; Ida A Heikura; Louise M Burke
Journal:  Sports Med       Date:  2019-12       Impact factor: 11.136

6.  Biphasic modulation of NOS expression, protein and nitrite products by hydroxocobalamin underlies its protective effect in endotoxemic shock: downstream regulation of COX-2, IL-1β, TNF-α, IL-6, and HMGB1 expression.

Authors:  André L F Sampaio; Jesmond Dalli; Vincenzo Brancaleone; Fulvio D'Acquisto; Mauro Perretti; Carmen Wheatley
Journal:  Mediators Inflamm       Date:  2013-05-28       Impact factor: 4.711

Review 7.  Mitochondria: a new therapeutic target in chronic kidney disease.

Authors:  Simona Granata; Alessandra Dalla Gassa; Paola Tomei; Antonio Lupo; Gianluigi Zaza
Journal:  Nutr Metab (Lond)       Date:  2015-11-25       Impact factor: 4.169

8.  Glutaredoxin-2 controls cardiac mitochondrial dynamics and energetics in mice, and protects against human cardiac pathologies.

Authors:  Georges N Kanaan; Bianca Ichim; Lara Gharibeh; Wael Maharsy; David A Patten; Jian Ying Xuan; Arkadiy Reunov; Philip Marshall; John Veinot; Keir Menzies; Mona Nemer; Mary-Ellen Harper
Journal:  Redox Biol       Date:  2017-10-26       Impact factor: 11.799

9.  Effect of N-Acetylcysteine on Antioxidant Defense, Oxidative Modification, and Salivary Gland Function in a Rat Model of Insulin Resistance.

Authors:  Piotr Żukowski; Mateusz Maciejczyk; Jan Matczuk; Krzysztof Kurek; Danuta Waszkiel; Małgorzata Żendzian-Piotrowska; Anna Zalewska
Journal:  Oxid Med Cell Longev       Date:  2018-01-30       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.